We are engaged in neurological disease research by converging reprogramming technology and data science for accelerating the transition to a sustainable disease-free society.
It is our dream to find a cure for irremediable neurological diseases with the power of science. We are innovating reprogramming-based research by its merger with the power of artificial intelligence and thereby challenging to reveal the mysterious reasons why neurodegeneration occurs, and to explore the question of what a human being is. We are working on the following projects:
-Research on the pathogenesis and treatment of neurological diseases including ALS and Alzheimer’s disease
-Neurodegeneration Research using machine learning
-Research on brain intelligence using primate stem cells.
We start with the thought "I wish I could do this, know this, and try this”. A “dream-driven approach” is the style of our laboratory.
img01.jpg

  • 2021.12.09
    32nd International Symposium on ALS/MND2021
    " ALS drug discovery using AI platform with patient iPSC panel,(Virtual)
  • 2021.12.08
    32nd International Symposium on ALS/MND2021
    " Clinical trial of bosutinib for amyotrophic lateral sclerosis: Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic Lateral Sclerosis Medicine (iDReAM) study,(Virtual)
  • 2021.10.22
    "Induction of inverted morphology in brain organoids by vertical-mixing bioreactors"

edit

>>All News Topics